Lose weight with a doctor who specializes in it, close to home. Darshan Patel, MD, an obesity medicine physician, and his care team see adults across Illinois by video, or in person at our clinic in Deer Park. We check your insurance before your first visit and handle prior authorization for brand-name medicine like Wegovy and Zepbound.
You meet with a physician, not just a form, and you keep the same care team from your first visit on.
Most major insurance accepted, plus convenient cash pay options. Whether a plan covers weight-loss medicine depends on the plan itself, so we check yours before your first visit. Here is what Illinois insurers and the state say publicly.
BCBSIL says GLP-1 coverage for weight management is optional for self-funded employer groups. For groups that choose it, Wegovy, including Wegovy HD, and the Zepbound auto-injector are on its drug lists; the Zepbound KwikPen, sold only direct to consumers, is excluded. (BCBSIL, May 2026)
From October 1, 2026, Illinois Medicaid covers Wegovy and Zepbound, with prior authorization, for certain FDA-approved uses: Wegovy to lower the risk of major heart events in adults with heart disease and obesity or overweight, or for MASH liver disease with moderate to advanced scarring, and Zepbound for moderate to severe sleep apnea in adults with obesity. It does not cover them for weight loss alone. (Illinois HFS, September 2026)
We check your benefits before your first visit, file the prior authorization, follow it through and appeal if your plan says no. When your plan covers the medicine, we help with the maker's copay assistance.
Not sure what your plan covers? Read how to check your GLP-1 coverage, or let us check it for you when you book. Live in the city? See GLP-1 weight care in Chicago.
Have Medicare? We bill Medicare for visits, and we prescribe through the Medicare GLP-1 Bridge for people who qualify: $50 a month, from July 1, 2026 to December 31, 2027. Self-pay plans are not offered at 65 and over. How the Medicare GLP-1 Bridge works.
We also see patients in California, Georgia, Indiana, Michigan, Ohio and Wisconsin. See all the states we serve.
Choose a self-pay plan with everything included: your medicine, shipping, consultations and messages with your care team. HSA and FSA cards accepted.
$475 for 12 weeks
That is $158.33 per 4 weeks. Or pay $200 every 4 weeks.
$675 for 12 weeks
That is $225 per 4 weeks. Or pay $300 every 4 weeks.
On the self-pay path, your first consultation is waived. A $50 fee applies only if you are prescribed medicine and decide not to start. There is no fee to cancel. A $35 missed-appointment fee applies, and your first one is waived. Self-pay plans are not offered at 65 and over. See pricing and what GLP-1 medicines cost without insurance.
Compounded medicines are prepared for you by a state-licensed pharmacy. They are not FDA-approved, are not reviewed by FDA for safety, effectiveness or quality, and are not the same as Wegovy, Ozempic, Zepbound or Mounjaro, or generic versions of them.
Tell us about your health and add your insurance from your card. We check your coverage before your consultation.
A physician-led visit by video, or in person in Deer Park. Billed to your plan; you pay any copay.
We submit it for brand-name medicine, follow up with your plan and appeal if needed. Once approved, your prescription goes to your pharmacy.
Follow-up visits, dose changes and messages with your care team in the app.
Have another question? Email support@aayuwell.com or call (312) 625-1889.
Yes. Adults anywhere in Illinois can see us by video. If you prefer to come in, our clinic is at 20330 N Deer Park Blvd, Suite 130, Deer Park, IL 60010. Call (312) 625-1889 with questions.
It depends on your plan. Blue Cross and Blue Shield of Illinois says GLP-1 coverage for weight management is optional for self-funded employer groups, so many members are covered only if their employer chose it. For groups that choose it, BCBSIL lists Wegovy, including Wegovy HD, and the Zepbound auto-injector on its drug lists, while the Zepbound KwikPen sold direct to consumers is excluded. We check your plan before your first visit.
Not for weight loss alone. From October 1, 2026, Illinois Medicaid covers Wegovy and Zepbound, with prior authorization, for certain other FDA-approved uses, such as lowering the risk of major heart events in adults with heart disease and obesity or overweight, or treating moderate to severe sleep apnea in adults with obesity. We check your plan before your first visit.
Yes. We bill Medicare for visits, and we prescribe through the Medicare GLP-1 Bridge for people who qualify: $50 a month, from July 1, 2026 to December 31, 2027. Self-pay plans are not offered at 65 and over.
Yes. We submit the prior authorization for brand-name medicine after your consultation and run it as a concierge service: the paperwork, the follow-up with your plan, and the appeal if your plan says no. When your plan covers the medicine, we also help with the maker's copay assistance. How long it takes depends on your plan.
We appeal first. If your plan still says no, we talk through every option together, including a self-pay plan: compounded semaglutide at $475 for 12 weeks or $200 every 4 weeks, or compounded tirzepatide at $675 for 12 weeks or $300 every 4 weeks, with medicine, shipping, consultations and care-team messages included.
Insurance coverage varies by plan, and prior authorization may be required. Medicine is prescribed when it is right for you, and individual results vary. Compounded medicines are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality. Insurer and state program details on this page are summarized from the public sources linked and can change; we check your plan before your first visit. See our Terms & Conditions.